Pharmaceuticals
QPS Announces Novel Coronavirus/COVID-19 Testing Capability
NEWARK, Delaware, May 12, 2020 /PRNewswire/ -- QPS, a global contract research organization (CRO) that provides GLP-compliant discovery, preclinical, and clinical drug development services, announces a newly developed capability to conduct COVID-19 testing, available as ofMonday, May 11, 2020. QP...
2020-05-12 19:11
2881
Merck Granted U.S. Patents for Foundational CRISPR-Cas9 Technology
- Technology provides more tools to fight difficult-to-treat diseases - Life Science business actively licensing its CRISPR-Cas9 technology for therapeutic and other uses - Committed to ethical use of genome-editing technology DARMSTADT, Germany, May 11, 2020 /PRNewswire/ -- Merck, a leading...
2020-05-11 21:00
2916
Technopath Clinical Diagnostics Expands Its Portfolio of Third-party Quality Control Solutions for COVID-19 as Clinical Laboratories Globally Ramp Up Antibody Testing
NEW YORK and BALLINA, Ireland, May 11, 2020 /PRNewswire/ -- Technopath Clinical Diagnostics today launched its Multichem ID-COVID-19 Quality Control Solutions offering laboratories third-party quality control products enabling an independent, totally unbiased assessment of a diagnostic device or ...
2020-05-11 14:00
3307
Daewoong Pharmaceutical Unveils Phase 3 Clinical Data of Fexuprazan, A Novel Potassium-competitive Acid Blocker
SEOUL, South Korea, May 11, 2020 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) unveiled for the first time the phase 3 clinical data of Fexuprazan, a novel gastroesophageal reflux disease agent at Digestive Disease Week (DDW) 2020. The abstract of Fexuprazan has been rated in the top 10% pos...
2020-05-11 08:00
5439
HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance
HANGZHOU, China, May 8, 2020 /PRNewswire/ -- HJB, a biologics CDMO committed to quality, reliability and speed for each and every CMCpackage delivered to its partners, today announces that its partner Mabspace Biosciences has received Investigational New Drug (IND) clearance from both the U.S. Fo...
2020-05-08 23:00
1986
Bridge Biotherapeutics Announces the IND Clearance of BBT-176, an EGFR TKI for NSCLC, in South Korea
* Following the US FDA's IND clearance, South Korea's MFDS cleared the IND application of BBT-176, submitted inDecember 2019 * BBT-176 will be the company's first drug candidate to launch clinical studies inSouth Korea * In the second half of this year, the company is expected to initiate a ...
2020-05-08 07:30
1718
Scientific Evidence Shows Everyday Hygiene Is Essential to Help Prevent the Spread of Infections, Reveals New Paper From The Global Hygiene Council
LONDON, May 8, 2020 /PRNewswire/ -- According to a new Position Paper published
in theAmerican Journal of Infection Control
2020-05-08 07:01
3819
DERMALOG Fever Detection at UKE Hamburg
HAMBURG, Germany, May 7, 2020 /PRNewswire/ -- Covid-19 currently shows how important it is to prevent the spread of infection as far as possible. Hospitals are facing a serious challenge, as staff and patients are at increased risk of infection. Fever screenings are increasingly being carried ...
2020-05-07 19:57
2988
Lipidor Presents Updated Project Plan - Initiates Phase III study of AKP02 in-House
STOCKHOLM, May 7, 2020 /PRNewswire/ -- In light of the company's successful Phase III study of calcipotriol spray (AKP01) against mild to moderate plaque psoriasis and subsequent discussions with pharmaceutical companies, the Board of Lipidor submits an updated project plan together with prioriti...
2020-05-07 18:20
2079
Lianhua Qingwen Receives Product Listing Approval from Singapore HSA
SHIJIAZHUANG, China, May 7, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) announced that it has obtained the product listing approval issued by the Health Sciences Authority (HSA) ofSingapore which grants Lianhua Qingwen Capsule the initial sale authorization in the country. The approval...
2020-05-07 15:14
63183
TWi Biotechnology Receives Canada Health Approval for AC-1101 Phase 1 CTA
TAIPEI, Taiwan, May 7, 2020 /PRNewswire/ -- TWi Biotechnology (TWiB) announced that they have received Clinical Trial Application (CTA) approval from the Health Canada to conduct a Phase 1 clinical trial with AC-1101 gel. AC-1101 is a topical JAK inhibitor for the potential treatment of patients ...
2020-05-07 14:06
3311
Sai Life Sciences Joins the Global 'COVID Moonshot' Project
HYDERABAD, India, May 7, 2020 /PRNewswire/ -- Sai Life Sciences, one of India's
fastest growingContract Development & Manufacturing Organizations (CDMOs)
2020-05-07 09:00
4154
Tyvyt® (Sintilimab Injection) Combined with Gemzar® (Gemcitabine for Injection) and Platinum Chemotherapy Met the Predefined Primary Endpoint in the Phase 3 ORIENT-12 Study as First-Line Therapy in Patients with Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
SUZHOU, China, May 6, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, autoimmune, metabolic and other major diseases, today jointly...
2020-05-07 07:30
10713
Yiling Pharmaceutical Releases Financial Report for Q1 2020, Covid-19 TCM Lianhua Qingwen Research and Achievements Drive Growth
SHIJIAZHUANG, China, May 6, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) has released its financial report for the first quarter of 2020. In the March quarter, Yiling Pharmaceutical achieved a total operating revenue of CNY 2.334 billion (USD $329 million) with 50.56% growth year-on-year...
2020-05-06 17:52
10491
Venturis Therapeutics, Inc. Announces its Applications for Four New Patents Related to the Use of Therapeutic Angiogenesis in the Treatment of Illnesses Related to the COVID-19 Virus, as Well as Illnesses Related to Other Viruses
DALLAS, May 6, 2020 /PRNewswire/ -- Venturis Therapeutics, Inc. ("VT") today announced it has applied for four provisional patents related to the treatment and/or prevention of virally induced illnesses related to the COVID-19 virus, as well as other viruses. These new patent applications cite th...
2020-05-06 09:26
2765
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment
AGC Biologics will manufacture novel precision cancer immunotherapy treatment Clevegen SEATTLE, May 5, 2020 /PRNewswire/ -- AGC Biologics, a global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has been selected to commercially manufacture the treatment Clevegen f...
2020-05-05 20:30
2932
Antengene Announces Expansion of Partnership with Karyopharm in Asia Pacific Markets
SHANGHAI, May 5, 2020 /PRNewswire/ -- Antengene Corporation (Antengene) today announced a broadened partnership and territory expansion agreement with Karyopharm Therapeutics Inc. (NASDAQ: KPTI) (Karyopharm) for development and commercialization of four oral novel drugs and drug candidates to s...
2020-05-05 20:30
2051
Ajinomoto Bio-Pharma Services Announces Manufacturing Partnership with CytoDyn for Drug Product Used in COVID-19 Clinical Trials
SAN DIEGO, May 5, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, is pleased to announce it has entered into a manufacturing services agreement with CytoDyn Inc., a late stage biotechno...
2020-05-05 20:05
2269
Tessa Therapeutics Announces New Executive Leadership
SINGAPORE, May 5, 2020 /PRNewswire/ -- Tessa Therapeutics (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments, today announced thatJeffrey H. Buchalter will assume the role of Chief Executive Officer, and Göran A. Ando will become Chairman of the Board, wi...
2020-05-05 00:00
2342
Ascentage Pharma's Core Drug Candidate HQP1351 Granted Orphan Drug Designation by the US FDA for the Treatment of Patients with Chronic Myeloid Leukemia
SUZHOU, China, and ROCKVILLE, Md., May 4, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug Adm...
2020-05-04 18:30
2181
Week's Top Stories
Most Reposted
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
[Picked up by 337 media titles]
2025-01-18 03:30
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
[Picked up by 311 media titles]
2025-01-18 17:00
Supported by the Luxembourg Government, The Luxembourg House of Financial Technology (LHoFT) and the Asian Development Bank (ADB) Announce the 2nd Edition of Catapult | SE Asia 2025
[Picked up by 310 media titles]
2025-01-22 15:38
dss⁺ Announces Strategic Changes to Executive Leadership Team in Asia Pacific Accelerating growth and impact for high-hazard industries in the region
[Picked up by 308 media titles]
2025-01-21 16:00
HARD ROCK HOTEL BALI ACHIEVES PRESTIGIOUS GSTC CERTIFICATION
[Picked up by 306 media titles]
2025-01-20 14:27
Most Read
LONG AN INTERNATIONAL PORT JOINS 12TH PORTECH ASIA SUMMIT 2025 IN MALAYSIA
2025-01-18 03:30
11685
Hong Kong Airlines Takes Off to Australia's Gold Coast Bringing Popular Travel Option for the Chinese New Year
2025-01-18 17:00
10653
Boosting Yeast Protein Production to Meet the Growing Global Demand for Alternative Proteins
2025-01-17 22:46
9860
Dongying's vibrant Spring Festival awaits visitors
2025-01-17 21:46
9756